Literature DB >> 12647909

Prevalence of obstructive airflow limitation in Irish collegiate athletes.

E Smith1, N Mahony, B Donne, M O'Brien.   

Abstract

BACKGROUND: Asthma prevalence in athletes is variable, depending on the sport and training conditions. AIMS: To investigate the prevalence of obstructive airflow limitation, asthma control and lung volume differences in a control group and five groups of collegiate athletes--outdoor field, indoor court, endurance, combat sports and swimming.
METHODS: Three hundred and five athletes completed a respiratory questionnaire and performed spirometry during normal training conditions, to determine FEV1, FVC and PEFR pre- and at 5, 10 and 15 minutes post-exercise. Between and within group analysis was carried out using single factor and repeated measures ANOVA.
RESULTS: Previous diagnosis of asthma was reported by 24%, outdoor field sports 4.9%, indoor court sports 2.3%, endurance events 2.6%, combat sports 3%, swimming 6.9% and controls 4.3%. Mean FEV1 and FVC data, expressed as percentage of predicted, were greatest in swimming and lowest in controls. Swimming showed a significant rise in FEV1 post-exercise, indoor court and endurance sports demonstrated no change and outdoor field, combat and control groups showed a fall in FEV1 post-exercise.
CONCLUSION: Warm humid training conditions appear protective against exercise-induced asthma. The greatest reductions in lung volumes occurred following high intensity exercise under cool conditions in the poorly aerobically conditioned.

Entities:  

Mesh:

Year:  2002        PMID: 12647909     DOI: 10.1007/bf03170281

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  20 in total

1.  Can peak expiratory flow predict airflow obstruction in children with asthma?

Authors:  N Eid; B Yandell; L Howell; M Eddy; S Sheikh
Journal:  Pediatrics       Date:  2000-02       Impact factor: 7.124

2.  Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen.

Authors:  I J Helenius; H O Tikkanen; T Haahtela
Journal:  Br J Sports Med       Date:  1998-06       Impact factor: 13.800

3.  Asthma in United States Olympic athletes who participated in the 1996 Summer Games.

Authors:  J M Weiler; T Layton; M Hunt
Journal:  J Allergy Clin Immunol       Date:  1998-11       Impact factor: 10.793

4.  Screening adolescent athletes for exercise-induced asthma.

Authors:  R A Feinstein; J LaRussa; A Wang-Dohlman; A A Bartolucci
Journal:  Clin J Sport Med       Date:  1996-04       Impact factor: 3.638

5.  Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors.

Authors:  I J Helenius; H O Tikkanen; S Sarna; T Haahtela
Journal:  J Allergy Clin Immunol       Date:  1998-05       Impact factor: 10.793

6.  Effects of swim training on lung volumes and inspiratory muscle conditioning.

Authors:  T L Clanton; G F Dixon; J Drake; J E Gadek
Journal:  J Appl Physiol (1985)       Date:  1987-01

7.  The large lungs of elite swimmers: an increased alveolar number?

Authors:  J Armour; P M Donnelly; P T Bye
Journal:  Eur Respir J       Date:  1993-02       Impact factor: 16.671

8.  Exercise-induced asthma screening of elite athletes: field versus laboratory exercise challenge.

Authors:  K W Rundell; R L Wilber; L Szmedra; D M Jenkinson; L B Mayers; J Im
Journal:  Med Sci Sports Exerc       Date:  2000-02       Impact factor: 5.411

Review 9.  Swimming and asthma. Benefits and deleterious effects.

Authors:  O Bar-Or; O Inbar
Journal:  Sports Med       Date:  1992-12       Impact factor: 11.136

Review 10.  Exercise-induced asthma: diagnosis and treatment for the recreational or elite athlete.

Authors:  W W Storms
Journal:  Med Sci Sports Exerc       Date:  1999-01       Impact factor: 5.411

View more
  1 in total

1.  Prevalence of exercise-induced bronchospasm in long distance runners trained in cold weather.

Authors:  Kağan Uçok; Senol Dane; Hakki Gökbel; Sedat Akar
Journal:  Lung       Date:  2004       Impact factor: 2.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.